Revenue segments as reported by the company.

Premiums

Products

Services

Investment and other income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Medical costs

Operating costs

Depreciation and amortization

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

UnitedHealth Group

Optum is a Health Services platform. It is a leading information and technology-enabled health services business dedicated to modernizing the system and improving the health of people and communities.

Optum

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Minnetonka, MN.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

UnitedHealth Group reports strong Q4 earnings and growth opportunities

UnitedHealth Group's Q4 2022 Earnings Call highlighted strong financial performance, growth initiatives, and confidence in sustainable earnings growth. The company is focused on enhancing consumer experiences, expanding value-based care, and driving growth through strategic investments and M&A priorities. Challenges include managing cost impacts from flu and respiratory issues, while opportunities lie in continued growth in key segments and strategic M&A.

UnitedHealth Group reports robust Q1 earnings, eyes growth opportunities

UnitedHealth Group's strong performance in Q1 2023 reflects growth across its segments, driven by a focus on value-based care and consumer-centric initiatives. While challenges exist with potential Medicare Advantage model changes, the company remains optimistic about sustained growth and opportunities for expansion.

UnitedHealth Group posts robust Q2 earnings, eyes tech-driven growth

UnitedHealth Group delivered strong financial performance in Q2 2023, with a focus on expanding patient care, driving cost efficiencies, and responding to changing healthcare dynamics. Challenges include margin pressures and managing investment gains unpredictability. Opportunities lie in leveraging technology for cost reduction and enhancing care capabilities post acquisitions.

UnitedHealth Group reports robust Q3 growth, eyes expansion in value-based care

UnitedHealth Group's Q3 performance showcased robust revenue growth and strengthened earnings outlook. The company's focus on value-based care, strong performance in pharmacy services, and investments in home care present opportunities for future growth. However, challenges related to wage inflation and margin impact at Optum Health require attention.

UnitedHealth Group posts strong 2023 results, eyes growth opportunities

UnitedHealth Group's 2023 performance showcased robust financial results, strategic investments in digital engagement, and a focus on improving healthcare quality and accessibility. While facing challenges in cost trends and industry dynamics, the company remains optimistic about its competitive positioning and growth prospects in 2024.

UnitedHealth Group resilient post-cyberattack, eyes growth opportunities

UnitedHealth Group navigated cyberattack impacts while maintaining outlook.
Strong response to challenges, focusing on growth and customer support.
Balanced approach to capital deployment and confidence in future opportunities.
Optimism in controlling costs and driving growth through innovation.

UnitedHealth Group reports resilient growth amidst cyberattack challenges

UnitedHealth Group's Q2 2024 performance reflects resilience and growth potential despite challenges from a cyberattack and other disruptions.
The company's strengths in customer recognition, Medicare Advantage programs, and technology innovation position it well for future success and market expansion.
While facing challenges like cyberattack impacts and medical care ratio issues, UnitedHealth Group remains focused on opportunities for growth and returning to baseline performance in 2025.

UnitedHealth Group affirms growth outlook amidst challenges, eyes 2025 strategy

UnitedHealth Group's Q3 2024 performance reflects strong revenue growth and a commitment to value-based care and innovation. Despite challenges like cyberattacks and care patterns impacting earnings outlook, the company remains focused on long-term growth objectives. UNH's strategic investments, focus on consumer experience, and capital deployment priorities signal a proactive approach to driving future growth.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

UnitedHealth Group is a dividend growth stock on its way to becoming a Dividend Aristocrat. The company delivered yet another double beat in the third quarter. UnitedHealth Group's net debt to adjusted EBITDA ratio is just above 1, which supports an A+ credit rating from S&P on a stable outlook.

UnitedHealth Group: Now A Fairly Valued Dividend-Growth Machine

UnitedHealth Group has underperformed the broader market in 2024 but shows potential for bullish activity in 2025 despite regulatory uncertainties. UNH delivered strong Q3 results with EPS of $7.15, beating expectations, and revenue of $101 billion, driven by higher service usage. Risks include policy uncertainty and potential premium increase restrictions, but the stock remains slightly undervalued with a target price near $618.

UnitedHealth: Navigating Policy Uncertainty Well, Solid EPS Growth Ahead

UnitedHealthcare navigates regulatory challenges, rising medical costs, and a cyberattack, maintaining growth and positioning for long-term success in a resilient healthcare sector. Despite temporary headwinds, UNH targets 13%-16% long-term earnings growth, supported by rising health expenditures and technological advancements. Optum Insight and Optum Health segments face short-term hurdles but are poised for future growth, enhancing UNH's value-based care strategy.

UnitedHealth Group: Preparing For December Investor Day, Buy Reiterated

Zacks.com users have recently been watching UnitedHealth (UNH) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

UnitedHealth Group Incorporated (UNH) is Attracting Investor Attention: Here is What You Should Know

FedEx

Visa

3 Dividend Growth Stocks That Have Increased Their Payouts by More Than 90% in 5 Years

Cigna

CVS Health

CVS Health, UnitedHealth Group and Cigna sued the Federal Trade Commission, claiming the agency's case against drug middlemen over high insulin prices in the U.S. is unconstitutional.  The complaint is the latest move in a bitter legal fight between the three largest pharmacy benefit managers, or PBMs, in the U.S. and the FTC.

CVS, UnitedHealth, Cigna sue to block FTC case over insulin prices

In the latest trading session, UnitedHealth Group (UNH) closed at $589.65, marking a -0.44% move from the previous day.

UnitedHealth Group (UNH) Stock Declines While Market Improves: Some Information for Investors

UNH and the broader health insurance industry will likely focus on cost-cutting initiatives and lobbying for better government reimbursement rates over time.

UnitedHealth Stock Up 12.7% YTD: Is its Premium Valuation Justified?

UnitedHealth (UNH) reported earnings 30 days ago. What's next for the stock?

UnitedHealth (UNH) Up 6% Since Last Earnings Report: Can It Continue?

Bank of America

SAP SE

UnitedHealth, Bank of America and SAP SE are included in this Analyst Blog.

The Zacks Analyst Blog UnitedHealth, Bank of America and SAP SE

Amedisys

The DOJ suggests that UNH's acquisitions reflect a strategy of buying competitors rather than competing directly, potentially giving it control over multiple markets.

DOJ Lawsuit Questions UnitedHealth's $3.3 Billion Amedisys Deal

The Justice Department and three U.S. states filed a lawsuit on Tuesday to block UnitedHealth Group's $3.3 billion purchase of Amedisys Inc over concern the deal would harm competition in the market for home health services, the department said.

US sues to block UnitedHealth's $3.3 bln purchase of Amedisys

The U.S. Justice Department is moving to block UnitedHealth Group's $3.3 billion purchase of Amedisys Inc. over concerns the deal would harm competition in the market for home health services, Bloomberg News reported on Tuesday, citing people familiar with the matter.

US Justice Department preps suit over UnitedHealth-Amedisys deal, Bloomberg News reports

Centene

Elevance Health Inc

Humana

Molina Healthcare

Several US health insurers saw notable stock price gains following the reelection of former US President Donald Trump amid an expectation of less federal scrutiny. Humana Inc. experienced the largest increase as its stock rose 10.7% from Nov. 1 through Nov. 6, increasing from $260.71 a share to $288.51 a share.

Trump Win Gives Some U.S. Health Insurers A Post-Election Bump On Wall Street

Pfizer

One stock yields 6% today. Another has grown its dividend by 460% over the past decade.

2 Healthcare Dividend Stocks That Are Screaming Buys in November

UnitedHealth Group Incorporated (UNH) Is a Trending Stock: Facts to Know Before Betting on It

BioNTech SE

HCA Healthcare

Eli Lilly

Tenet Healthcare

Universal Health Services

Health Care Select Sector SPDR Fund

Investors are worried about what a Trump administration means for hospital operators and vaccine makers, but are optimistic about the fate of Medicare Advantage plan providers.

Why most healthcare stocks are falling with Trump's win, with some exceptions

Oscar Health

Market reactions sharply diverged among healthcare companies as investors expect changes to Obamacare, Medicare.

Trump Will Create New Winners and Losers in Healthcare

--(BUSINESS WIRE)--UnitedHealth Group Quarterly Dividend.

UnitedHealth Group Board Authorizes Payment of Quarterly Dividend

CVS Health on Wednesday named Steve Nelson, a former UnitedHealth insurance head, to run its Aetna business, where rising medical costs in the third quarter caused the company to preannounce an earnings miss last month.

CVS taps former UnitedHealth executive to run insurance unit Aetna

Lockheed Martin

Wall Street and other financial heavyweights have placed enormous bets on the 2024 election. Billionaire Paul Tudor Jones has said he will pull out of markets completely in the event of a Harris victory, while Elon Musk has said Warren Buffett's recent selling spree is for the same reason.

2 Stocks To Buy No Matter Who Becomes President

Accenture Plc

Amphenol

Domino's Pizza

Global Payments

Intuit

Lam Research

Mastercard

Microchip Technology

MSCI

Nordson

ResMed

Rollins

SPDR S&P 500 ETF Trust

Vanguard Dividend Appreciation ETF

Zoetis

The SPDR S&P 500 ETF Trust posted a loss of 0.89% in October, putting a pause on its strong run in 2024. The Top 15 dividend growth stocks for November 2024 offer an average dividend yield of 1.24% and appear to be about 23% undervalued based on dividend yield theory. Since its inception in September 2020, the watch list has achieved an 11.33% compound annual growth rate.

My Top 15 High-Growth Dividend Stocks For November 2024

--(BUSINESS WIRE)--UnitedHealthcare has announced a significant expansion of its Individual & Family Affordable Care Act (ACA) Marketplace plans, now offering coverage in 30 states. This increase includes new coverage areas in Indiana, Iowa, Nebraska and Wyoming, as well as additional counties in 13 other states. With the inclusion of these new coverage areas, UnitedHealthcare now provides Individual & Family ACA Marketplace plans in over 1,250 counties across the following states: Alab.

UnitedHealthcare Expands its Individual & Family Plans on the Health Insurance Marketplace to 30 States

Abbott Labs

Intuitive Surgical

Investors looking for health-related buy-and-hold stocks must look no further than this list. The stocks on this list are market leaders in healthcare, producing sustainable growth with healthy balance sheets, impressive value, and broad market support.

These Are The Top Health Stocks to Own for Buy-and-Hold Investing

American Express

Danaher

New Linde PLC

Microsoft

Texas Instruments

These seven companies are transforming steady profits into rising passive income streams for investors.

News for UnitedHealth Group Stock (UNH)